People news: Biocodex USA and 3-V Biosciences

Share this article:
Biocodex USA hired Dr. Andres Tellez as principal, business development and strategy, responsible for in-licensing or acquiring new therapeutics to market for the US subsidiary of Biocodex, a French pharmaceutical firm.

3-V Biosciences promoted Stephen Brady to chief business officer. Brady joined the firm in 2010 as VP, corporate development, strategy & operations, with management responsibility for the company's business functions. Prior to joining 3-V, he was VP of corporate development for Proteolix. Brady also worked at Lexicon Pharmaceuticals, where he served in business development, communications and corporate legal capacities, and was a VP with Lazard Venture Advisors, a division of Lazard Freres & Co.
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in People Moves

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in People Moves

Monday Moves: October 20

Promotions and hires for agencies and manufacturers

Monday Moves: September 29

Promotions and hires for agencies and manufacturers

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media